Log In
Print this Print this

RepliCel Tendon-01 (RCT-01)

  Manage Alerts
Collapse Summary General Information
Company RepliCel Life Sciences Inc.
DescriptionFibroblasts isolated from non-bulbar dermal sheath (NBDS) cells from a patient's healthy hair follicles that are replicated using RepliCel technology
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationTissue damage
Indication DetailsTreat Achilles tendinosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today